Fourth webinar in the series: From research and innovation to development: how to plan and execute translational projects in life sciences, this edition looks more closely at IP protection strategies for translational research.
It focuses on intellectual property (IP) and spin-out strategies in the human healthcare sector. A well-designed IP strategy, tailored to the type of innovation, is crucial for the long-term success of university spin-outs.
Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements. They’ll share insights on the essential components of an IP strategy for the healthcare sector and discuss how these components vary based on the type of innovation—whether in biotech, pharma, or digital health—and the intended business model.
It is always encouraging to see that other TTOs are encountering the same problems that we do!
Aurore De Boom
Université Libré de Bruxelle, Belgium
The experts, the specific content and the informal setting will improve you as a professional.
Brechtje Vreenegoor
Radboud Universteit, Netherlands
There was ample opportunity to learn from colleagues through the workshop sessions or more formally through speakers either sharing their years of experience or their state of the art research. Well worth attending.
John Gleeson
University of Limerick, Ireland
Starting or changing any procedure at a TTO/Institution is challenging and I could not think of anything better than learning with the best.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
ASTP's conference helped us to network with decision-makers in the technology transfer industry and provides a great platform to discuss future innovation in this sector.
Christopher Römer
Inventtory, Germany
Join our newsletter and get the latest news